These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3086422)

  • 1. Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.
    Paradisi R; Venturoli S; Pasquali R; Capelli M; Porcu E; Fabbri R; Flamigni C
    J Endocrinol Invest; 1986 Apr; 9(2):139-44. PubMed ID: 3086422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary-ovarian relationships in polycystic ovary syndrome.
    Baird DT; Corker CS; Davidson DW; Hunter WM; Michie EA; Van Look PF
    J Clin Endocrinol Metab; 1977 Oct; 45(4):798-801. PubMed ID: 334789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the endogenous opioid system in the pathogenesis of polycystic ovary syndrome: the altered neuroendocrine regulation of GnRH-LH is corrected after clomiphene therapy].
    Barletta C; Vagiri D; Scavo D
    Minerva Endocrinol; 1992; 17(3):107-19. PubMed ID: 1298870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of pituitary gonadotropes to a constant infusion of luteinizing hormone-releasing hormone (LHRH) in normal prepubertal and pubertal children and in children with abnormalities of sexual development.
    Reiter EO; Root AW; Duckett GE
    J Clin Endocrinol Metab; 1976 Aug; 43(2):400-11. PubMed ID: 780368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A; Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?
    Dunaif A
    J Clin Endocrinol Metab; 1986 Jul; 63(1):215-21. PubMed ID: 3086357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL; Rigg LA; Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.
    Steingold K; De Ziegler D; Cedars M; Meldrum DR; Lu JK; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary gonadotropin responses to synthetic luteinizing hormone-releasing hormone in patients with typical and atypical polycystic ovary disease.
    Patton WC; Berger MJ; Thompson IE; Chong AP; Grimes EM; Taymor ML
    Am J Obstet Gynecol; 1975 Feb; 121(3):382-6. PubMed ID: 1090169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist.
    Chang RJ; Laufer LR; Meldrum DR; DeFazio J; Lu JK; Vale WW; Rivier JE; Judd HL
    J Clin Endocrinol Metab; 1983 May; 56(5):897-903. PubMed ID: 6403570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
    Dunaif A; Graf M
    J Clin Invest; 1989 Jan; 83(1):23-9. PubMed ID: 2642919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of serum gonadotrophins to LH-releasing hormone and oestrogens in Japanese women with polycystic ovaries.
    Aono T; Miyazaki M; Miyake A; Kinugasa T; Kurachi K; Matsumoto K
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):840-9. PubMed ID: 196471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intractable, ovary-independent impairment in hypothalamo-pituitary function in the estradiol-valerate-induced polycystic ovarian condition in the rat.
    Simard M; Brawer JR; Farookhi R
    Biol Reprod; 1987 Jun; 36(5):1229-37. PubMed ID: 3113503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.